Ardelyx reported $-407K in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Amgen USD 1.82B 486M Mar/2026
Ardelyx USD -407K 562K Dec/2025
aTyr Pharma USD 24.56M 50.3M Dec/2025
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Curis USD 19.36M 31.16M Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
TG Therapeutics USD 19.78M 3.26M Mar/2026
United Therapeutics USD 274.9M 89.4M Mar/2026
Xoma USD -17.24M 33.23M Sep/2024